Tumor Immunology Flashcards
2 key cytokines that down-regulate T cell responses
TGF-beta and IL-10
Ligand that provides activatory signals to NK cells
MIC
MIC ligand provides activatory signals to NK cells through this
NKG2D
MIC ligand activates these cells
NK cells
Pembrolizumab, Nivolumab, and Cemiplimab are monoclonal antibodies against this
PD-1
Atezolizumab, Avelumab, and Durvalumab are monoclonal antibodies against this
PD-L1
PD-L1/PD-1 binding has this effect
Inhibits T cell killing of tumor cell
Blocking PD-L1/PD-1 binding has this effect
Allows T cell killing of tumor cell
Antigen for Gemtuzumab
CD33
CD33 is a marker for these
Immature myeloid cells
Gemtuzumab is used for this disease
Acute myelogenous leukemia
Ibritumomab is used for this disease
Non-Hodgkin’s lymphoma
Tositumomab is used for this disease
Non-Hodgkin’s Lymphoma
Monoclonal antibody against CD33 for treatment of acute myelogenous leukemia
Gemtuzumab
2 monoclonal antibodies that target CD20 in the treatment of Non-Hodgkin’s Lymphoma
Ibritumomab and Tositumomab